1. State the objectives and funding of each programme and summarize the principal research and development activities conducted in the programme. Areas to be addressed shall include: prophylaxis, studies on pathogenicity and virulence, diagnostic techniques, aerobiology, detection, treatment, toxinology, physical protection, decontamination and other related research.
The Home Office (HO) co-ordinates the CONTEST programme. The research undertaken under this programme is aimed at enhancing the UK’s capability to minimise the risk of a CBRN terrorist incident. Areas addressed include:
- Detection and analysis of biological materials
- Hazard assessment and decontamination of biological agents
- Developing an understanding of the impact and spread of biological materials
- Hazard prevention of biological materials
2. State the total funding for each programme and its source.
Funding source
Home Office
Total Funding Amount:
170,000
Funding Currency:
GBP
3. Are aspects of these programmes conducted under contract with industry, academic institutions, or in other non-defence facilities?
no
4. If yes, what proportion of the total funds for each programme is expended in these contracted or other facilities?
Not applicable
5. Summarize the objectives and research areas of each programme performed by contractors and in other facilities with the funds identified under paragraph 4.
Not applicable
6. Provide a diagram of the organizational structure of each programme and the reporting relationships (include individual facilities participating in the programme).
See diagram
Diagram Upload
N/A
7. Provide a declaration in accordance with Form A, part 2 (iii) for each facility, both governmental and non-governmental, which has a substantial proportion of its resources devoted to each national biological defence research and development programme, within the territory of the reporting State, or under its jurisdiction or control anywhere.
The only facility that falls into this category is Dstl, Porton Down, for which a declaration is made on Form A Part 2 (iii).